NC

Nisha Cyriac

Active Director Director DIN 02532250
DIN 02532250 First appointment Apr 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2009
Shareholding value •••• Premium profile

About Nisha Cyriac

Data last updated:

Nisha Cyriac is a Director at Encare Medical Devices Private Limited (since 2009). The company operates in Healthcare. Encare Medical Devices Private Limited reported revenue of ₹16.54 Cr (FY 2025).

DIN 02532250
Primary Designation Director
Industry Healthcare
First Appointment 06 Apr 2009
Oldest Company Age 17 yrs
Largest company Encare Medical Devices Private Limited · ₹16.54 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20092009₹16.54 Cr (FY 2025)Active

Board colleagues of Nisha Cyriac

Directorship timeline

Open interactive timeline →
Encare Medical Devices Private Limited
Premium access

Shareholding and investment profile for Nisha Cyriac

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nisha Cyriac

Nisha Cyriac currently holds 1 directorship: Encare Medical Devices Private Limited (Director, since 06 Apr 2009, revenue ₹16.54 Cr (FY 2025)).

Nisha Cyriac was first appointed on 06 Apr 2009 as Director at Encare Medical Devices Private Limited.

The current boards of Nisha Cyriac's companies include Cyriac James Nirappel (Encare Medical Devices Private Limited), Rosamma Thomas (Encare Medical Devices Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available